期刊文献+

努力拓展供肝来源 被引量:2

原文传递
导出
摘要 进入21世纪,肝移植已经成为治疗终末期肝病和肝功能衰竭的一种最有效的方法。目前,我国肝移植受者术后1年存活率已达到90%以上,但供肝短缺严重制约了肝移植的应用。我国肝移植供、受者之比高达150:1。为此,必须致力于扩大供者来源。
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2012年第4期193-194,共2页 Chinese Journal of Organ Transplantation
基金 江苏省十二五“兴卫工程”基金(ZX201105) 卫生部科研课题(LW201008)
  • 相关文献

参考文献9

  • 1Elias-Miro M,Massip-Salcedo M,Jimenez-Castro M. Does adiponectin benefit steatotic liver transplantation[J].Liver Transplantation,2011,(09):993-1004.
  • 2Tekin K,Imber CJ,Atli M. A simple scoring system to evaluate the effects of cold ischemia on marginal liver donors[J].Transplantation,2004,(03):411-416.doi:10.1097/01.TP.0000110318.70879.20.
  • 3McCormack L,Petrowsky H,Jochum W. Use of severely steatotic grafts in liver transplantation:a matched case-control study[J].Annals of Surgery,2007,(06):940-948.doi:10.1097/SLA.0b013e31815c2a3f.
  • 4Iamo JM,Barrera L,Mar n LM. Results of liver transplantation with donors older than 70 years:a case-control study[J].Transplantation Proceedings,2011,(06):2227-2229.
  • 5Chin JH,Kim YK,Choi WJ. A retrospective case control study of intraoperative cardiac dysfunction in elderly patients(≥ 60 years)undergoing live donor liver transplantation[J].Transplantation Proceedings,2011,(05):1678-1683.doi:10.1016/j.transproceed.2011.01.168.
  • 6Cholongitas E,Papatheodoridis GV,Burroughs AK. Liver grafts from anti-hepatitis B core positive donors:a systematic review[J].Journal of Hepatology,2010,(02):272-279.doi:10.1016/j.jhep.2009.11.009.
  • 7Loggi E,Micco L,Ercolani G. Liver transplantation from hepatitis B surface antigen positive donors:a safe way to expand the donor pool[J].Journal of Hepatology,2012,(03):579-585.doi:10.1016/j.jhep.2011.09.016.
  • 8丁义涛.乙型肝炎相关性肝脏疾病的肝移植治疗[J].肝胆外科杂志,2005,13(2):91-93. 被引量:7
  • 9Kotulski M,Pawlak J,Hevelke P. Assessment of early graft function in relation to different preservation fluidspreliminary results[J].Annals of Transplantation,2003,(04):31-35.

二级参考文献6

  • 1Adam R, MeMaster P, O'grady JG, et al. Evolution of Liver Transplantation in Europe: Report of the European Liver Transplant Registry[J]. Liver Transpl,2003,9 : 1231-1243.
  • 2Bernal W. Changing patterns of causation and the use of transplantation in the United kingdom[J]. Semin Liver Dis,2003,23:227-237.
  • 3Marsh JW, Dvorchik I. Liver organ allocation for hepatoeellularcarcinoma; Are we sure[J]? Liver Transpl, 2003,9 : 1394-1403.
  • 4Bigourdan JM, Jaeck D, Meyer N, et al. Small hepatocellularcar cinoma in Child A Cirrhotic patients: Hepatic Resection versus transplantation[J]. Liver Transpl, 2003,9 : 513-520.
  • 5Hu RH, Ho MC, Wu YM, et al . Feasibility of salvage liver transplantation for patients with recurrent hepatoeellular carcinoma [J]. Clin Transplant, 2005,19 : 175-80.
  • 6Pokorny H, Gnant M, Rasoul-Rockenschaub S, et al. Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation[J] ? Am J Transplant, 2005,5 : 788-794.

共引文献6

同被引文献36

  • 1朱志军,高伟,孟醒初,张雅敏,蒋文涛,张建军,张玮晔,沈中阳.脂肪沉着供肝在肝脏移植中的应用[J].中华肝胆外科杂志,2005,11(9):627-629. 被引量:7
  • 2McCormack L1, Dutkowski P, E1-Badry AM, et al. Liver transplantation using fatty livers : always feasible? [ J ]. Hepatol, 2011, 54(5) : 1055-1062.
  • 3Chui AK, Haghighi K, Painter D, et al. Donaor fatty (steatotic)liver allografts in orthotopie liver transplantation [ J ]. Transplant Proc, 1998, 30(7): 3286-3287.
  • 4Chavin KD, Taber DJ, Norcross M, et al. Safe use of highly steatotic livers by utilizingadonor/recipient clinical algorithm [ J 1. Clin Transplant, 2013, 27(5): 732-741.
  • 5DeAlwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears [ J ]. J Hepatol, 2008, 48 ( 1 ) : 104-112.
  • 6Petrowsky H, McCormack L, Trujillo M, et al. A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus isehemic preconditioning with continuous clamping for major liver resection [ J~. Ann Surg, 2006, 244 (6) : 921- 928.
  • 7Angele MK, Rentsch M, Hartl WH, et al. Effect of graft steatosis on liver function and organ survival after liver transplantation [ J 1. Am J Surg, 2008, 195(2) : 214-220.
  • 8Marsman WA, Wiesner RH, Rodriguez L, et al. Use of fatty donor liver is associated with diminished early patient and graft survival[J1. Transplantation, 1996, 62(9) : 1246-1251.
  • 9Verran D, Kusyk T, Painter D, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopie liver transplantation[J~. Liver Transpl, 2003, 9(5) : 500-505.
  • 10Spitzer AL, Lao OB, Dick AA, et al. The biopsied donor liver, incorporating macrosteatosis into high-risk donor assessment [ J ]. Liver Transpl, 2010, 16(7) : 874-884.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部